Electrical Stimulation Blood Pressure Treatment Devices Market By Product Type (External Electrical Stimulation Devices, Implantable Electrical Stimulation Devices), By End-User Industry (Hospitals, Home Care Settings, Ambulatory Surgical Centers), By Application (Hypertension Treatment, Stroke Recovery, Cardiac Rehabilitation), By Technology (Transcutaneous Electrical Nerve Stimulation (TENS), Implantable Electrical Stimulation, Pulsed Electrical Stimulation); Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Electrical Stimulation Blood Pressure Treatment Devices Market was valued at USD 6.5 billion in 2023 and will surpass USD 12.3 billion by 2030; growing at a CAGR of 9.6% during 2024 - 2030.

The global electrical stimulation blood pressure treatment devices market has witnessed substantial growth due to increasing demand for non-invasive solutions for hypertension management. These devices use electrical impulses to stimulate specific nerve endings or muscles, which can help regulate blood pressure and improve cardiovascular health. The demand for such devices has surged with the rising prevalence of hypertension and associated conditions, such as stroke and cardiac diseases. Furthermore, the growing focus on enhancing patient comfort and minimizing hospital visits has driven the market’s expansion, with more advanced and targeted solutions entering the market. As the technology evolves, the market is expected to expand across different product types, end-user industries, and applications.

External Electrical Stimulation Devices Segment is Fastest Growing Owing to Non-Invasive Treatment Options

External electrical stimulation devices have emerged as the fastest-growing segment in the electrical stimulation blood pressure treatment devices market. This growth is largely driven by their non-invasive nature, ease of use, and increased acceptance among patients who seek alternatives to more invasive treatments. Unlike implantable devices, external devices can be used at home, offering convenience for patients and reducing hospital visits, which significantly contributes to their rising popularity. They are often based on Transcutaneous Electrical Nerve Stimulation (TENS), a technology that involves delivering electrical impulses to the skin via electrodes. This approach is not only effective but also safe, making it an appealing choice for those managing hypertension and related cardiovascular issues.

As the market for external electrical stimulation devices continues to expand, companies are focusing on improving device efficiency and patient compliance. Innovations such as portable, user-friendly, and smart devices that monitor blood pressure in real time are becoming increasingly common. These devices offer patients enhanced control over their health and treatment, aligning with the growing demand for personalized, at-home healthcare solutions.

Electrical Stimulation Blood Pressure Treatment Devices Market Size

Hospitals Segment is Largest Due to Demand for Specialized Care

Hospitals represent the largest end-user industry in the electrical stimulation blood pressure treatment devices market. Hospitals are the primary healthcare settings where most patients with hypertension or related complications receive treatment, making them the largest segment for these devices. The prevalence of hypertension, stroke, and other cardiovascular issues necessitates the use of advanced treatments, and electrical stimulation devices are becoming integral in the management of these conditions. With access to skilled professionals and the latest technologies, hospitals are well-equipped to administer and monitor the use of these devices for effective hypertension management and recovery.

Additionally, hospitals are increasingly adopting these devices for stroke recovery and cardiac rehabilitation, providing patients with more comprehensive treatment options. As hospitals continue to prioritize innovative treatment methods for blood pressure regulation and cardiovascular health, the demand for electrical stimulation devices will remain strong.

Hypertension Treatment Application is Largest Due to Growing Prevalence

Hypertension treatment is the largest application segment for electrical stimulation blood pressure treatment devices. High blood pressure is one of the most common cardiovascular diseases globally, with millions of individuals suffering from this condition. Electrical stimulation devices offer a promising non-pharmacological treatment option for managing hypertension, especially for patients who prefer drug-free solutions or who cannot tolerate the side effects of medications. This application is experiencing rapid growth due to increasing awareness about the importance of hypertension management and the benefits of electrical stimulation technologies.

Devices such as TENS units, which use mild electrical pulses to stimulate nerves and regulate blood pressure, are widely utilized in the treatment of hypertension. As the global prevalence of hypertension continues to rise, the demand for effective, non-invasive treatment options like electrical stimulation devices is expected to remain robust. These devices not only help in lowering blood pressure but also aid in improving overall cardiovascular health, which further drives their adoption.

Transcutaneous Electrical Nerve Stimulation (TENS) Technology is Largest Due to Effectiveness and Safety

Transcutaneous Electrical Nerve Stimulation (TENS) technology is the largest segment in terms of technology used in electrical stimulation devices for blood pressure treatment. TENS technology is widely known for its effectiveness in managing pain and is now being increasingly employed to regulate blood pressure. This non-invasive method works by delivering electrical impulses to the skin’s surface through electrodes, stimulating the nerves and influencing the body’s cardiovascular system to reduce blood pressure. The ease of use, safety, and efficiency of TENS have contributed to its widespread adoption.

TENS devices are also portable and cost-effective, which makes them a preferred choice for patients seeking at-home treatment. This technology has seen continuous improvements in terms of user-friendly features, enhanced functionality, and real-time blood pressure monitoring, all of which further contribute to its growth. As healthcare providers continue to promote TENS-based devices for blood pressure regulation, the technology is poised to remain dominant in the market.

North America Region is Largest Due to Advanced Healthcare Infrastructure

North America is the largest region in the electrical stimulation blood pressure treatment devices market. The region benefits from a well-established healthcare infrastructure, widespread access to advanced medical technologies, and a high prevalence of hypertension and cardiovascular diseases. The United States, in particular, has a large number of patients with hypertension, creating a significant demand for effective treatment options like electrical stimulation devices. Additionally, the increasing adoption of homecare and telehealth solutions is further driving the growth of this market in North America.

The presence of leading healthcare providers, research institutions, and manufacturers of electrical stimulation devices in the U.S. also fuels market growth. Government initiatives aimed at improving cardiovascular health and reducing hypertension-related complications further contribute to the market’s expansion in this region. North America is expected to maintain its leadership in the market as healthcare systems continue to embrace advanced treatment solutions for hypertension and stroke recovery.

Electrical Stimulation Blood Pressure Treatment Devices Market Size by Region 2030

Competitive Landscape and Leading Companies

The electrical stimulation blood pressure treatment devices market is highly competitive, with numerous companies focusing on developing innovative products to address the growing need for hypertension management solutions. Leading companies such as Medtronic, Abbott Laboratories, Nevro Corporation, and Boston Scientific Corporation dominate the market with their advanced device offerings. These companies have invested heavily in research and development to enhance device capabilities, improve patient outcomes, and expand their market presence globally.

The competitive landscape is characterized by strategic partnerships, acquisitions, and technological advancements. Companies are also working to expand their product portfolios by introducing new features such as real-time monitoring, smart connectivity, and integration with mobile health platforms. The market is also seeing an influx of new entrants, driven by the increasing demand for non-invasive treatments and advancements in electrical stimulation technologies. As the market grows, innovation, customer support, and product differentiation will continue to play key roles in shaping the competitive dynamics.

List of Leading Companies:

  • Medtronic PLC
  • Boston Scientific Corporation
  • Nevro Corporation
  • Abbott Laboratories
  • Bioelectronics Corporation
  • Nuvoton Technology
  • Zynex Inc.
  • Soterix Medical Inc.
  • Hivox Biotek
  • Cerbomed GmbH
  • ReShape Lifesciences
  • Oratec Interventions
  • Transneuronix
  • Zeta Surgical
  • Neuregenix

Recent Developments:

  • Medtronic: Medtronic recently launched a new line of TENS therapy devices specifically designed for hypertension management, expanding their portfolio in blood pressure treatment.
  • Nevro Corporation: Nevro announced the approval of its implantable electrical stimulation device for stroke recovery in several international markets.
  • Abbott Laboratories: Abbott has acquired a startup specializing in non-invasive blood pressure regulation technology, furthering its expansion in hypertension solutions.
  • Bioelectronics Corporation: Bioelectronics received FDA approval for a new wearable device aimed at chronic hypertension treatment using electrical stimulation.
  • Soterix Medical Inc.: Soterix launched a clinical trial program to assess the efficacy of their TENS-based device for post-stroke rehabilitation and blood pressure control

Report Scope:

Report Features

Description

Market Size (2023)

USD 6.5 Billion

Forecasted Value (2030)

USD 12.3 Billion

CAGR (2024 – 2030)

9.6%

Base Year for Estimation

2023

Historic Year

2022

Forecast Period

2024 – 2030

Report Coverage

Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments

Segments Covered

Electrical Stimulation Blood Pressure Treatment Devices Market By Product Type (External Electrical Stimulation Devices, Implantable Electrical Stimulation Devices), By End-User Industry (Hospitals, Home Care Settings, Ambulatory Surgical Centers), By Application (Hypertension Treatment, Stroke Recovery, Cardiac Rehabilitation), By Technology (Transcutaneous Electrical Nerve Stimulation (TENS), Implantable Electrical Stimulation, Pulsed Electrical Stimulation)

Regional Analysis

North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa)

Major Companies

Medtronic PLC, Boston Scientific Corporation, Nevro Corporation, Abbott Laboratories, Bioelectronics Corporation, Nuvoton Technology, Zynex Inc., Soterix Medical Inc., Hivox Biotek, Cerbomed GmbH, ReShape Lifesciences, Oratec Interventions, Transneuronix, Zeta Surgical, Neuregenix

Customization Scope

Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements

1. Introduction

   1.1. Market Definition

   1.2. Scope of the Study

   1.3. Research Assumptions

   1.4. Study Limitations

2. Research Methodology

   2.1. Research Approach

      2.1.1. Top-Down Method

      2.1.2. Bottom-Up Method

      2.1.3. Factor Impact Analysis

  2.2. Insights & Data Collection Process

      2.2.1. Secondary Research

      2.2.2. Primary Research

   2.3. Data Mining Process

      2.3.1. Data Analysis

      2.3.2. Data Validation and Revalidation

      2.3.3. Data Triangulation

3. Executive Summary

   3.1. Major Markets & Segments

   3.2. Highest Growing Regions and Respective Countries

   3.3. Impact of Growth Drivers & Inhibitors

   3.4. Regulatory Overview by Country

4. Electrical Stimulation Blood Pressure Treatment Devices Market, by Product Type (Market Size & Forecast: USD Million, 2022 – 2030)

   4.1. External Electrical Stimulation Devices

   4.2. Implantable Electrical Stimulation Devices

   4.3. Others

5. Electrical Stimulation Blood Pressure Treatment Devices Market, by End-User Industry (Market Size & Forecast: USD Million, 2022 – 2030)

   5.1. Hospitals

   5.2. Home Care Settings

   5.3. Ambulatory Surgical Centers

   5.4. Others

6. Electrical Stimulation Blood Pressure Treatment Devices Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030)

   6.1. Hypertension Treatment

   6.2. Stroke Recovery

   6.3. Cardiac Rehabilitation

   6.4. Others

7. Electrical Stimulation Blood Pressure Treatment Devices Market, by Technology (Market Size & Forecast: USD Million, 2022 – 2030)

   7.1. Transcutaneous Electrical Nerve Stimulation (TENS)

   7.2. Implantable Electrical Stimulation

   7.3. Pulsed Electrical Stimulation

   7.4. Others

8. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030)

   8.1. Regional Overview

   8.2. North America

      8.2.1. Regional Trends & Growth Drivers

      8.2.2. Barriers & Challenges

      8.2.3. Opportunities

      8.2.4. Factor Impact Analysis

      8.2.5. Technology Trends

      8.2.6. North America Electrical Stimulation Blood Pressure Treatment Devices Market, by Product Type

      8.2.7. North America Electrical Stimulation Blood Pressure Treatment Devices Market, by End-User Industry

      8.2.8. North America Electrical Stimulation Blood Pressure Treatment Devices Market, by Application

      8.2.9. North America Electrical Stimulation Blood Pressure Treatment Devices Market, by Technology

      8.2.10. By Country

         8.2.10.1. US

               8.2.10.1.1. US Electrical Stimulation Blood Pressure Treatment Devices Market, by Product Type

               8.2.10.1.2. US Electrical Stimulation Blood Pressure Treatment Devices Market, by End-User Industry

               8.2.10.1.3. US Electrical Stimulation Blood Pressure Treatment Devices Market, by Application

               8.2.10.1.4. US Electrical Stimulation Blood Pressure Treatment Devices Market, by Technology

         8.2.10.2. Canada

         8.2.10.3. Mexico

    *Similar segmentation will be provided for each region and country

   8.3. Europe

   8.4. Asia-Pacific

   8.5. Latin America

   8.6. Middle East & Africa

9. Competitive Landscape

   9.1. Overview of the Key Players

   9.2. Competitive Ecosystem

      9.2.1. Level of Fragmentation

      9.2.2. Market Consolidation

      9.2.3. Product Innovation

   9.3. Company Share Analysis

   9.4. Company Benchmarking Matrix

      9.4.1. Strategic Overview

      9.4.2. Product Innovations

   9.5. Start-up Ecosystem

   9.6. Strategic Competitive Insights/ Customer Imperatives

   9.7. ESG Matrix/ Sustainability Matrix

   9.8. Manufacturing Network

      9.8.1. Locations

      9.8.2. Supply Chain and Logistics

      9.8.3. Product Flexibility/Customization

      9.8.4. Digital Transformation and Connectivity

      9.8.5. Environmental and Regulatory Compliance

   9.9. Technology Readiness Level Matrix

   9.10. Technology Maturity Curve

   9.11. Buying Criteria

10. Company Profiles

   10.1. Medtronic PLC

      10.1.1. Company Overview

      10.1.2. Company Financials

      10.1.3. Product/Service Portfolio

      10.1.4. Recent Developments

      10.1.5. IMR Analysis

    *Similar information will be provided for other companies 

   10.2. Boston Scientific Corporation

   10.3. Nevro Corporation

   10.4. Abbott Laboratories

   10.5. Bioelectronics Corporation

   10.6. Nuvoton Technology

   10.7. Zynex Inc.

   10.8. Soterix Medical Inc.

   10.9. Hivox Biotek

   10.10. Cerbomed GmbH

   10.11. ReShape Lifesciences

   10.12. Oratec Interventions

   10.13. Transneuronix

   10.14. Zeta Surgical

   10.15. Neuregenix

11. Appendix

 

A comprehensive market research approach was employed to gather and analyze data on the Electrical Stimulation Blood Pressure Treatment Devices Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Electrical Stimulation Blood Pressure Treatment Devices Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.

Research Approach - Electrical Stimulation Blood Pressure Treatment Devices Market

Secondary Research

Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.

Primary Research

Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:

  • Validating findings and assumptions derived from secondary research
  • Gathering qualitative and quantitative data on market trends, drivers, and challenges
  • Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
  • Assessing the supply-side landscape, including technological advancements and recent developments

Market Size Assessment

A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Electrical Stimulation Blood Pressure Treatment Devices Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:

  1. Identification of key industry players and relevant revenues through extensive secondary research
  2. Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
  3. Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources

Bottom Up and Top Down - Electrical Stimulation Blood Pressure Treatment Devices Market

Data Triangulation

To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.

NA

Please state your requirements.


I have read the Terms & Conditions and Privacy Policy. I agree to its terms.

Report Buying Options